INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 33 filers reported holding INHIBRX INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,847,869 | -39.5% | 1,517,595 | -14.3% | 0.00% | -50.0% |
Q2 2023 | $45,994,163 | -24.3% | 1,771,732 | -44.9% | 0.00% | +33.3% |
Q1 2023 | $60,724,680 | +45.8% | 3,218,054 | +90.3% | 0.00% | -25.0% |
Q4 2022 | $41,657,246 | +31.9% | 1,690,635 | -3.9% | 0.00% | +33.3% |
Q3 2022 | $31,582,000 | +92.6% | 1,759,455 | +21.8% | 0.00% | +50.0% |
Q2 2022 | $16,397,000 | -49.1% | 1,444,642 | -0.1% | 0.00% | -33.3% |
Q1 2022 | $32,213,000 | -48.0% | 1,445,861 | +1.9% | 0.00% | -40.0% |
Q4 2021 | $61,983,000 | +28.7% | 1,419,361 | -1.9% | 0.01% | +25.0% |
Q3 2021 | $48,172,000 | +19.8% | 1,446,167 | -1.0% | 0.00% | +33.3% |
Q2 2021 | $40,219,000 | +28.0% | 1,461,471 | -6.6% | 0.00% | 0.0% |
Q1 2021 | $31,409,000 | -40.4% | 1,564,982 | -2.1% | 0.00% | -40.0% |
Q4 2020 | $52,680,000 | +67.7% | 1,597,827 | -8.4% | 0.01% | +66.7% |
Q3 2020 | $31,410,000 | – | 1,745,026 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |